Affordable Access

deepdyve-link
Publisher Website

Response to the Letter to the Editor Regarding "Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials".

Authors
  • Suez, Daniel1
  • Stein, Mark2
  • Gupta, Sudhir3
  • Hussain, Iftikhar4
  • Melamed, Isaac5
  • Paris, Kenneth6
  • Darter, Amy7
  • Bourgeois, Christelle8
  • Fritsch, Sandor8
  • Leibl, Heinz8
  • McCoy, Barbara9
  • Gelmont, David10
  • Yel, Leman11
  • 1 Allergy, Asthma and Immunology Clinic PA, Irving, TX, USA.
  • 2 Allergy Associates of the Palm Beaches, North Palm Beach, FL, USA.
  • 3 Division of Basic and Clinical Immunology, University of California at Irvine, Irvine, CA, USA.
  • 4 Vital Prospects Clinical Research Institute, Tulsa, OK, USA.
  • 5 IMMUNOe International Research Centers, Centennial, CO, USA.
  • 6 LSU Health Sciences Center, Children's Hospital, New Orleans, LA, USA.
  • 7 Oklahoma Institute of Allergy and Asthma Clinical Research, LLC, Oklahoma City, OK, USA.
  • 8 Shire, Vienna, Austria. , (Austria)
  • 9 Shire, Cambridge, MA, USA.
  • 10 Shire, Westlake Village, CA, USA.
  • 11 Shire, Cambridge, MA, USA. [email protected]
Type
Published Article
Journal
Journal of Clinical Immunology
Publisher
Springer-Verlag
Publication Date
Nov 01, 2017
Volume
37
Issue
8
Pages
739–740
Identifiers
DOI: 10.1007/s10875-017-0438-y
PMID: 28875256
Source
Medline
License
Unknown
Report this publication

Statistics

Seen <100 times